11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration: the resilience of a potent androgen in prostate cancer patients after castration
Gido Snaterse, Lisanne Van Dessel, Job Van Riet, Angela Taylor, Michelle Van Der Vlugt-Daane, Paul Hamberg, Prof Ronald de Wit, Jenny A. Visser, Wiebke Arlt, Martijn Lolkema, Johannes Hofland
Research output: Contribution to journal › Article › peer-review
155Downloads
(Pure)
Fingerprint
Dive into the research topics of '11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration: the resilience of a potent androgen in prostate cancer patients after castration'. Together they form a unique fingerprint.